WB
The company develops targeted radiopharmaceuticals using a proprietary technology platform that selects specific targeting ligands and radiation drug-conjugates for clinical applications. This approach aims to provide effective treatment options for patients with significant unmet medical needs in oncology.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The company develops targeted radiopharmaceuticals using a proprietary technology platform that selects specific targeting ligands and radiation drug-conjugates for clinical applications. This approach aims to provide effective treatment options for patients with significant unmet medical needs in oncology.